Memory loss and confusion are just a few of the symptoms associated with Alzheimer’s disease. And sadly, the disease is already quite advanced by the time patients begin exhibiting symptoms and an official diagnosis is given, making it rather difficult to treat. Past studies have indicated that there is potential for eye exams to aid in earlier detection of Alzheimer’s disease, as have advances in research Healio Optometry recently reported on, which have revealed there may be potential for a new method of earlier detection of Alzheimer’s, perhaps long before patients start presenting symptoms.
Neurologists have determined the presence of amyloid beta protein deposits as a “biomarker” of Alzheimer’s. Amyloid can also accumulate in the eye, leading researchers to theorize, “If a correlation can be made between the amyloid in the eye and the amyloid in the brain, then it would be possible to diagnose [Alzheimer’s] by looking into the eye.”
With this theory in mind, researchers are working to develop tests that will detect these amyloid beta deposits in the eyes. One test, currently referred to as the “Retinal Amyloid Index,” takes a scan similarly to conventional retinal imaging devices, after the patient has taken a curcumin …![]()